Prevalence of Fabry Disease in patients with left ventricular hypertrophy in Turkey: Multicenter study (LVH-TR subgroup analysis).
Fatma Nihan Turhan CaglarFatma Nihan Turhan ÇağlarMehmet KışMehmet KışSelvi ÖztaşGulay GökZeynep KolakZeynep KolakErcan AkşitSüleyman Anıl SarıcaOğuzhan BirdalOğuzhan BirdalMesut GitmezMesut GitmezGül İlayda BerkAli Nazmi CalikAli Nazmi ÇalıkMehdi ZoghiMehdi ZoghiAsım Oktay ErgenePublished in: The international journal of cardiovascular imaging (2023)
In daily cardiology practice, FD should be kept in mind not only in adult patients with unexplained LVH but also in the entire LVH population. Dry blood test (DBS) should be considered in high-risk patients, and mutation analysis should be considered in required patients.
Keyphrases
- end stage renal disease
- ejection fraction
- left ventricular
- newly diagnosed
- chronic kidney disease
- prognostic factors
- primary care
- peritoneal dialysis
- healthcare
- randomized controlled trial
- coronary artery disease
- cardiac surgery
- aortic stenosis
- quality improvement
- deep brain stimulation
- mitral valve
- replacement therapy
- patient reported
- double blind